These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29902460)

  • 1. The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
    Ke F; Yu J; Chen W; Si X; Li X; Yang F; Liao Y; Zuo Z
    Biochem Biophys Res Commun; 2018 Oct; 504(2):374-379. PubMed ID: 29902460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evidence of synergism between atovaquone and chemotherapy by AMPK-dependent mitochondrial dysfunction.
    Xie F; Gong J; Tan H; Zhang H; Ma J
    Eur J Pharmacol; 2021 Sep; 907():174256. PubMed ID: 34129882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
    Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
    Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
    Xiao Q; Yang L; Hu H; Ke Y
    J Bioenerg Biomembr; 2020 Apr; 52(2):113-121. PubMed ID: 31965456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
    Chen D; Sun X; Zhang X; Cao J
    J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallic acid targets acute myeloid leukemia via Akt/mTOR-dependent mitochondrial respiration inhibition.
    Gu R; Zhang M; Meng H; Xu D; Xie Y
    Biomed Pharmacother; 2018 Sep; 105():491-497. PubMed ID: 29883944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
    Sun Y; Xu H; Chen X; Li X; Luo B
    Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temsirolimus as a dual inhibitor of retinoblastoma and angiogenesis via targeting mTOR signalling.
    Chen Z; Yang H; Li Z; Xia Q; Nie Y
    Biochem Biophys Res Commun; 2019 Aug; 516(3):726-732. PubMed ID: 31253398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage.
    Xiong Y; Liu W; Huang Q; Wang J; Wang Y; Li H; Fu X
    Sci Rep; 2018 Aug; 8(1):11747. PubMed ID: 30082885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
    Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An α-acetoxy-tirucallic acid isomer inhibits Akt/mTOR signaling and induces oxidative stress in prostate cancer cells.
    El Gaafary M; Büchele B; Syrovets T; Agnolet S; Schneider B; Schmidt CQ; Simmet T
    J Pharmacol Exp Ther; 2015 Jan; 352(1):33-42. PubMed ID: 25316122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupivacaine inhibits angiogenesis through oxidative stress-dependent inhibition of Akt/mTOR and activation of AMPK.
    Zhu Q; Zhu G; Xu W; Dan J; Xia R; Liu W
    Fundam Clin Pharmacol; 2020 Oct; 34(5):581-590. PubMed ID: 32145095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitochondrial translation as a therapeutic strategy for human ovarian cancer to overcome chemoresistance.
    Hu B; Guo Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):373-378. PubMed ID: 30591219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatase control of 4E-BP1 phosphorylation state is central for glycolytic regulation of retinal protein synthesis.
    Gardner TW; Abcouwer SF; Losiewicz MK; Fort PE
    Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E546-56. PubMed ID: 26199279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical evidence that salinomycin is active against retinoblastoma via inducing mitochondrial dysfunction, oxidative damage and AMPK activation.
    Li J; Min Y
    J Bioenerg Biomembr; 2021 Oct; 53(5):513-523. PubMed ID: 34365583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells.
    Zhang H; Kong X; Kang J; Su J; Li Y; Zhong J; Sun L
    Toxicol Sci; 2009 Aug; 110(2):376-88. PubMed ID: 19451193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: energy depletion, oxidative stress, and protein kinase activity modulation.
    Calviño E; Estañ MC; Sánchez-Martín C; Brea R; de Blas E; Boyano-Adánez Mdel C; Rial E; Aller P
    J Pharmacol Exp Ther; 2014 Feb; 348(2):324-35. PubMed ID: 24307199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.